Skip to main content

Madrigal Pharmaceuticals, Inc.

MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001157601

In the last 90 days, Madrigal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 414 institutions reported holding it in 13F filings for Q2 2026, worth $12.7B in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Madrigal Pharmaceuticals, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of MDGL: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders2663257−6
Shares21.1M27.5K22.9M+1.79M (+8.5%)
Value$5.64B$7.33M$6.41B+$777.9M (+13.8%)

3 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (49)

Institutions that held Madrigal Pharmaceuticals, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to MDGL in Q2 2024
InstitutionSharesValue% of portfolio
Fiera Capital Corp115,415$32.3M0.10%
Schonfeld Strategic Advisors LLC24,460$6.85M0.05%
Corebridge Financial, Inc.9,438$2.64M0.01%
Mirae Asset Global ETFs Holdings Ltd.8,954$2.52M0.01%
J. Safra Sarasin Holding AG5,751$1.61M0.03%
Squarepoint Ops LLC5,170$1.45M0.01%
Wolverine Trading, LLC4,582$1.28M0.02%
Assetmark, Inc3,639$1.02M0.00%
Brinker Capital Investments, LLC3,477$974.1K0.01%
Orion Portfolio Solutions, LLC3,477$974.1K0.01%
Bayesian Capital Management, LP3,409$955.1K0.11%
Stifel Financial Corp2,968$831.5K0.00%
Eisler Capital (US) LLC2,885$808.3K0.15%
Balyasny Asset Management LLC2,448$685.8K0.00%
Marshall Wace, LLP1,700$476.3K0.00%
Brown Advisory Inc1,500$420.2K0.00%
Oppenheimer Asset Management Inc.1,476$413.5K0.01%
Snowden Capital Advisors LLC1,462$409.6K0.01%
Algert Global LLC1,269$355.5K0.01%
Inceptionr LLC1,159$324.7K0.09%
Torno Capital, LLC1,000$280.2K0.03%
Colony Group, LLC970$272.0K0.00%
Dorsey & Whitney Trust CO LLC934$261.7K0.02%
Envestnet Portfolio Solutions, Inc.898$251.6K0.00%
Atria Investments LLC893$250.2K0.00%
Axq Capital, LP892$249.9K0.06%
Two Sigma Securities, LLC862$241.5K0.01%
Truist Financial Corp772$216.3K0.00%
JustInvest LLC728$204.0K0.00%
Sanctuary Advisors, LLC1,051$203.2K0.00%
D.A. Davidson & Co.715$200.3K0.00%
Centaurus Financial, Inc.583$163.0K0.01%
IFP Advisors, Inc341$95.5K0.00%
Jones Financial Companies LLLP335$93.9K0.00%
Danske Bank A/S100$28.0K0.00%
Spire Wealth Management100$28.0K0.00%
Mather Group, LLC.73$19.4K0.00%
Ashton Thomas Private Wealth, LLC30$8.40K0.00%
Smartleaf Asset Management LLC27$7.71K0.00%
International Assets Investment Management, LLC20$5.60K0.00%
Massmutual Trust Co FSB17$4.76K0.00%
Farther Finance Advisors, LLC11$3.07K0.00%
Hollencrest Capital Management10$2.80K0.00%
Whittier Trust Co of Nevada Inc7$1.96K0.00%
Ronald Blue Trust, Inc.6$1.60K0.00%
Park Place Capital Corp4$1.12K0.00%
Continuum Advisory, LLC3$8400.00%
Innealta Capital, LLC2$5600.00%
CVA Family Office, LLC2$5600.00%

Sold out (55)

Institutions that held Madrigal Pharmaceuticals, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of MDGL in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Ra Capital Management, L.P.204,500$54.6M
Bain Capital Life Sciences Investors, LLC196,995$52.6M
Artal Group S.A.110,507$29.5M
Lord, Abbett & Co. LLC97,103$25.9M
Sio Capital Management, LLC51,000$13.6M
Driehaus Capital Management LLC50,709$13.5M
Twin Tree Management, LP30,297$8.09M
Ghisallo Capital Management LLC25,000$6.68M
LMR Partners LLP22,108$5.90M
Candriam Luxembourg S.C.A.18,000$4.81M
Blue Owl Capital Holdings LP13,319$3.56M
Adage Capital Partners GP, L.L.C.10,000$2.67M
Cubist Systematic Strategies, LLC9,013$2.41M
American International Group, Inc.7,292$1.95M
Ghost Tree Capital, LLC6,500$1.74M
Martingale Asset Management L P6,163$1.65M
Millennium Management LLC5,653$1.51M
Pentwater Capital Management LP4,000$1.07M
Capital Impact Advisors, LLC3,726$995.0K
Knott David M Jr3,584$957.0K
HealthInvest Partners AB3,539$945.1K
Tudor Investment Corp Et Al3,258$870.0K
Susquehanna Fundamental Investments, LLC2,186$583.7K
Seaport Global Advisors, LLC2,136$570.4K
FNY Investment Advisers, LLC2,075$554.0K
Soros Fund Management LLCSuperinvestorSoros Fund Management2,016$538.4K
XTX Topco Ltd1,980$528.7K
PEAK6 Investments LLC1,874$500.5K
Omers Administration Corp1,800$480.7K
Symmetry Investments LP1,500$400.6K
SG Americas Securities, LLC1,347$360.0K
Congress Park Capital LLC1,200$320.4K
Qube Research & Technologies Ltd1,158$309.2K
Wealth Enhancement Advisory Services, LLC973$259.8K
Sassicaia Capital Advisers LLC900$240.3K
PFG Investments, LLC858$229.1K
Sumitomo Mitsui Trust Holdings, Inc.839$224.0K
Mackenzie Financial Corp799$213.4K
Metropolitan Life Insurance Co778$207.8K
Liberty One Investment Management, LLC549$146.6K
Catalyst Funds Management Pty Ltd300$80.1K
BNP Paribas255$68.1K
EntryPoint Capital, LLC155$41.4K
Quantbot Technologies LP100$26.7K
ICA Group Wealth Management, LLC90$24.0K
CoreCap Advisors, LLC68$18.2K
Headlands Technologies LLC61$16.3K
Leonteq Securities AG40$10.7K
Nelson, Van Denburg & Campbell Wealth Management Group, LLC29$7.74K
Meeder Asset Management Inc10$2.67K
Bokf, NA10$2.56K
Farmers & Merchants Trust Co of Chambersburg PA8$2.00K
Westend Capital Management, LLC4$1.07K
Riggs Asset Managment Co. Inc.2$535
Atlas Capital Advisors LLC1$267

Not filed for Q2 2024 yet (3)

Institutions that held Madrigal Pharmaceuticals, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding MDGL in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Cutler Group LP15,800$4.22M
Credit Suisse AG11,603$3.10M
Cambridge Trust Co65$17.4K